Similar articles

• Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.

  Devrim S, Koniçe M, Sencer E, Molvalìlar S, Alp H. Devrim S, et al. Isr J Med Sci. 1972 Jun;8(6):815-20. Isr J Med Sci. 1972. PMID: 5051802 No abstract available.
• Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.

  Deckert T, Lauridsen UB, Madsen SN, Mogensen P. Deckert T, et al. Dan Med Bull. 1972 Oct;19(7):222-6. Dan Med Bull. 1972. PMID: 5079926 No abstract available.
• Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.

  Bagdade JD, Bierman EL, Porte D Jr. Bagdade JD, et al. Metabolism. 1971 Nov;20(11):1000-7. doi: 10.1016/0026-0495(71)90022-9. Metabolism. 1971. PMID: 5115750 No abstract available.
• [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].

  Vague P, Vague J. Vague P, et al. Journ Annu Diabetol Hotel Dieu. 1972;13(0):55-65. Journ Annu Diabetol Hotel Dieu. 1972. PMID: 4605752 Review. French. No abstract available.
• Evaluation of islet-cell function in man.

  Arky RA, Knopp RH. Arky RA, et al. N Engl J Med. 1971 Nov 11;285(20):1130-1. doi: 10.1056/NEJM197111112852006. N Engl J Med. 1971. PMID: 4937863 Review. No abstract available.